1. Home
  2. Browse Decisions
  3. F.3d
  4. 677 F.3d
  5. 677 F.3d 1298 (2012)
 

F.T.C. v. WATSON PHARMACEUTICALS, INC.

No. 10-12729.

677 F.3d 1298 (2012)

FEDERAL TRADE COMMISSION, Plaintiff-Counter Defendant-Appellant, v. WATSON PHARMACEUTICALS, INC., Solvay Pharmaceuticals, Inc., Defendants-Appellees, Par Pharmaceutical Companies, Inc., Paddock Laboratories, Inc., Defendants-Counter Claimants-Appellees.

United States Court of Appeals, Eleventh Circuit.

April 25, 2012.

Attorney(s) appearing for the Case

Imad Dean Abyad , Bradley S. Albert , John F. Daly , Markus H. Meier , John R. Robertson , Mark J. Woodward , FTC, Office of Gen. Counsel, Lore A. Unt , U.S. FTC, Washington, DC, Cindy A. Liebes , FTC, Atlanta, GA, for Plaintiff-Appellant.

Jason W. Eakes , David A. Rabin , Morris, Manning & Martin, LLP, Mark Gerald Trigg , Greenberg Traurig, LLP, Teresa Thebaut Bonder , Matthew Kent , Alston & Bird, LLP, Atlanta, GA, Maris A. Raptis , Skadden, Arps, Slate, Meagher & Flom, LLP, New York City, Steven Craig Sunshine , Julia K. York , Skadden, Arps, Slate, Meagher & Flom, LLP, J. Mark Gidley , Eric Grannon , White & Case, LLP, John Roberti , Rebecca Valentine, Mayer Brown, LLP, Washington, DC, Jeffrey I. Weinberger , Munger, Tolles & Olson, LLP, Los Angeles, CA, Rohit K. Singla , Munger, Tolles & Olsen, LLP, San Francisco, CA, for Defendants-Appellees.

Before CARNES, KRAVITCH, and FARRIS, Circuit Judges.

CARNES, Circuit Judge:

The system of developing new drugs in this country exemplifies the maxims "no risk, no reward" and "more risk, more reward." Developing new drugs is a risky, lengthy, and costly endeavor, but it also can be highly lucrative. Only one in every 5,000 medicines tested for the potential to treat illness is eventually approved for patient use, and studies estimate that developing a new drug takes 10 to 15 years and costs more than $1.3 billion.

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases